Clinical Study
Portable Gentle Jogger Improves Glycemic Indices in Type 2 Diabetic and Healthy Subjects Living at Home: A Pilot Study
Table 2
Twenty-four-hour average glycemia and indices in healthy subjects at baseline, during, and after Gentle Jogger jogging device (JD).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values for twenty-four-hour mean glucose (mGlu, mg/dl), sum of 24 hr glucose (SUM mg/dl), coefficient of variation (%CV), and 24 hr area under the glucose curve (AUC), in healthy subjects. % time in range (TIR, glucose between 70 and 180 mg/dl, % time below range (TBR, ). Data are expressed as the mean (SD, standard deviation). The time points are 24 hr prior to operation of JD (BL), after 2, 3, 4, 5, 6, and 7 days of JD (JD2, JD3, JD4, JD5, JD6, JD7), and 24 and 48 hr after discontinuation of JD (Post JD1, Post JD2). Statistical significance vs. BL. |